Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda. (2016)
Attributed to:
Safety of discontinuing Cotrimoxazole Prophylaxis among African adults on ART. A randomised controlled trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.conctc.2016.05.008
PubMed Identifier: 27536738
Publication URI: http://europepmc.org/abstract/MED/27536738
Type: Journal Article/Review
Volume: 3
Parent Publication: Contemporary clinical trials communications
ISSN: 2451-8654